SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
30 hedge funds and large institutions have $55.9M invested in Sorrento Therapeutics, Inc. in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
+15
Holders Change %
+100%
% of All Funds
0.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
19
Increased
5
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$8.97M |
2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.09M |
3 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
+$1.28M |
4 |
B
Baird
Milwaukee,
Wisconsin
|
+$880K |
5 |
Jane Street
New York
|
+$850K |
Top Sellers
1 |
![]()
JPMorgan Chase & Co
New York
|
-$2.12M |
2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.8M |
3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$413K |
4 |
SC
Sophrosyne Capital
New York
|
-$316K |
5 |
Bank of America
Charlotte,
North Carolina
|
-$284K |